AGP Executive Report
Last update: 8 hours agoMedical Cannabis Policy: Georgia’s medical cannabis program is getting a major expansion under Senate Bill 220, effective July 1, widening eligibility, adding product options, and letting patients access treatment earlier after diagnosis. Access & Compliance: Alabama’s long-stalled medical marijuana rollout is finally moving—Callie’s Apothecary opens in Montgomery May 4, with more dispensaries expected soon as the state awards licenses and patients begin submitting certifications. Rescheduling Legal Fallout: A new legal discussion highlights how moving state-licensed medical marijuana from Schedule I to Schedule III could reshape prescribing, fulfillment authority, patient safety duties, and insurance coverage. Research & Health Claims: Animal and lab-focused reports keep coming—phytocannabinoids may reduce alcohol intake in rats, and cannabinoids show anti-tumor promise in glioblastoma reviews. Youth & Risk: New research links heavy social media use with higher odds of teens trying cannabis, pointing to impulsivity and risk-taking rather than anxiety alone. Potency Warnings: One report argues modern cannabis is far stronger than decades ago, raising concerns about anxiety, panic, and psychosis risk—especially with high-THC concentrates. International Regulation: Japan is set to ban the cannabis ingredient CBN starting June, while Vermont continues pushing weedkiller bans tied to Parkinson’s risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
